PTEN and neoplasm: In addition, the loss of PTEN in melanoma, prostate cancer, and glioblastoma tumors is associated with decreased T‐cell function, increased VEGF production, and the release of anti‐inflammatory cytokines, leading to an increase in noninflammatory tumors and changes in tumor microenvironment.